1Krishnan J,Kirkin V,Steffen A,et al. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats [J]. Cancer Research, 2003; 63(3) : 713.
2Joukov V,Sorsa T,Kumar V,et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C [J]. EMBO J,1997;16:3898.
3Achen MG,Jeltsch M,Kukk E,et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flkl) and VEGF receptor 3 (Flt4)[J]. Proc Natl Acad Sci USA,1998;95:548.
4Folkman J. Seminars in Medicine of Beth Israel Hospital.clinical applications of research in angiogenesis [J]. N Engl J Med, 1995 ; 333 : 1757.
5Thomas KA. Vascular endothelial growth factor, a potent and selective angiogenic agent[J]. J Biol Chem,1996;271:603.
6Gitay-Goren H,Cohen T,Tessler S,et al. Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cens [J]. J Biol Chem, 1996;271:5519.
7Keyt BA,Nguyen HV,Berleau LT,et al. Identification of vascular endothelial growth factor determinants for binding KDR and Flt-1 receptors[J]. J Biol Chem,1996;271:5638.
8Ferrara N,Davis-Smyth T. The biology of vascular endothelial growth factor[J]. Endocr Rev,1997;18:4.
9Gerber HP, Dixit V, Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cens [J]. J Biol Chem 1998 ; 273 : 13313.
10Benjamin LE,Golijanin D,Itin A,et al. Selective ablation of immature blood vessels in established human tumors fonows vascular endothelial growth factor withdrawal[J]. J Clin Invest,1999;103:159.
